Non-Clinical Safety Assesment, IND & NDA Enabling Studies With Bioanalysis (Non-Clinical & Clinical)

Intox is an OECD GLP-certified preclinical safety assessment service provider with 25+ years of expertise in conducting safety assessment studies for small and large molecules. The state-of-the-art facility is spread across 45,000 sq ft in Pune, India. Our scientific team of experts includes board-certified toxicologists (DABTs), pathologists (ACVP and DIBTP), study directors, study personnel, veterinarians, analysts, and QA personnels.

Over the years, we have conducted more than 16,000 GLP studies for a wide range of industries including pharmaceutical, bio-pharmaceutical, medical device, agrochemical, industrial chemical, nutraceuticals/dietary supplements, cosmetics and others.

• Subsidiary of Aragen Life Sciences
• Track record of successful data submissions to regulatory agencies of US-FDA, US-EPA, Canada, European Union, UK, Brazil, Argentina, Japan, India, Australia and China
• State-of-the-art, ABSL2-compliant vivarium with multispecies capacity, enabling you to start up to
  several hundred animal studies at a given time
• AAALAC accredited and CCSEA compliant facilities
• 25,000 square feet vivarium
• SPF rodents from Charles River Inc., Taconic and Jackson Laboratories
• 25 Years of expertise in GLP safety assessment, IND enabling studies, carcinogenicity & clinical

Timeline can be optimised upon understanding of molecule and regulatory pathway

New Chemical Entitles

• Simultaneous methods for prodrugs and its two active metabolites
• 6-substituted-3h-1,3-benzothiazole
• Bisbenzimidazole HCL
• Gemcitabine
• 6-Substituted dimethyl pyridine 3 sulfonamide